| microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells E Bandres, N Bitarte, F Arias, J Agorreta, P Fortes, X Agirre, R Zarate, ... Clinical Cancer Research 15 (7), 2281-2290, 2009 | 500 | 2009 |
| Wells' syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin‐5 A España, ML Sanz, J Sola, P Gil British Journal of Dermatology 140 (1), 127-130, 1999 | 126 | 1999 |
| Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears MD Lozano, A Panizo, GR Toledo, JJ Sola, J Pardo‐Mindán Cancer Cytopathology 93 (1), 68-72, 2001 | 122 | 2001 |
| Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance RG de la Garza, P Sarobe, J Merino, JJ Lasarte, D D'Avola, V Belsue, ... Liver Transplantation 19 (9), 937-944, 2013 | 113 | 2013 |
| 18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer G Zornoza, MJ Garcia-Velloso, J Sola, FM Regueira, L Pina, C Beorlegui European Journal of Surgical Oncology (EJSO) 30 (1), 15-19, 2004 | 108 | 2004 |
| Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer G Toledo, JJ Sola, MD Lozano, E Soria, J Pardo Modern pathology 17 (4), 440-448, 2004 | 103 | 2004 |
| Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer J Rodríguez, R Zarate, E Bandres, V Boni, A Hernández, JJ Sola, ... European journal of cancer 48 (12), 1774-1780, 2012 | 101 | 2012 |
| Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery J Arredondo, J Baixauli, C Pastor, A Chopitea, JJ Sola, I González, ... Clinical and Translational Oncology 19, 379-385, 2017 | 82 | 2017 |
| The diffuse endocrine system: from embryogenesis to carcinogenesis LM Montuenga, L Guembe, MA Burrell, ME Bodegas, A Calvo, JJ Sola, ... Progress in Histochemistry and Cytochemistry 38 (2), 153-272, 2003 | 79 | 2003 |
| A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients E Bandrés, R Malumbres, E Cubedo, B Honorato, R Zarate, A Labarga, ... Oncology reports 17 (5), 1089-1094, 2007 | 73 | 2007 |
| Large cell carcinoma of the lung: an endangered species? J Pardo, AM Martinez-Peñuela, JJ Sola, A Panizo, A Gúrpide, ... Applied Immunohistochemistry & Molecular Morphology 17 (5), 383-392, 2009 | 70 | 2009 |
| Liver changes in patients with hyperthyroidism J Sola, FJ Pardo‐Mindan, J Zozaya, J Quiroga, B Sangro, J Prieto Liver 11 (4), 193-197, 1991 | 67 | 1991 |
| Perineural invasion is a major prognostic and predictive factor of response to adjuvant chemotherapy in stage I–II colon cancer JA Cienfuegos, P Martínez, J Baixauli, C Beorlegui, S Rosenstone, ... Annals of surgical oncology 24, 1077-1084, 2017 | 66 | 2017 |
| Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy J Arredondo, J Baixauli, C Beorlegui, L Arbea, J Rodríguez, JJ Sola, ... Diseases of the colon & rectum 56 (4), 416-421, 2013 | 61 | 2013 |
| Tumor response assessment in locally advanced colon cancer after neoadjuvant chemotherapy J Arredondo, I González, J Baixauli, P Martínez, J Rodríguez, C Pastor, ... Journal of Gastrointestinal Oncology 5 (2), 104, 2014 | 60 | 2014 |
| Accuracy of endoscopic ultrasound to assess tumor response after neoadjuvant treatment in rectal cancer: can we trust the findings? C Pastor, JC Subtil, J Sola, J Baixauli, C Beorlegui, L Arbea, J Aristu, ... Diseases of the colon & rectum 54 (9), 1141-1146, 2011 | 59 | 2011 |
| Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery JA Cienfuegos, F Rotellar, J Baixauli, C Beorlegui, JJ Sola, L Arbea, ... Annals of surgical oncology 22, 916-923, 2015 | 52 | 2015 |
| Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial L Arbea, R Martínez-Monge, JA Díaz-González, M Moreno, J Rodríguez, ... International Journal of Radiation Oncology* Biology* Physics 83 (2), 587-593, 2012 | 44 | 2012 |
| Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer JJ Aristu, L Arbea, J Rodriguez, JL Hernández-Lizoain, JJ Sola, ... International Journal of Radiation Oncology* Biology* Physics 71 (3), 748-755, 2008 | 44 | 2008 |
| Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms. XC Xu, JJ Sola Gallego, R Lotan, AK El-Naggar International journal of oncology 17 (2), 271-277, 2000 | 44 | 2000 |
Fernando PardoClínica Universidad de NavarraVerified email at unav.es
